×

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

  • US 8,618,130 B2
  • Filed: 01/25/2013
  • Issued: 12/31/2013
  • Est. Priority Date: 01/16/2003
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of treating psychosis, or a symptom thereof, comprising administering to a patient suffering from psychosis, or a symptom thereof, a therapeutically effective amount of a compound of formula (I):

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×